Medical News

Morbid Obesity is a Risk Factor for Infection Recurrence Fol...

Our findings suggest morbidly obese patients face an increased risk of DAIR failure, however this risk can be...

07 Jul 2020

Risk of Prosthetic Joint Infection Increases Following Early...

Early aseptic revision surgery following THA and TKA is associated with significantly increased risks of subsequent...

06 Jul 2020

Effect of bisphosphonates or teriparatide on mechanical comp...

The overall mechanical complication rate was lower in patients who received TP than in those who received a BP...

03 Jul 2020

Risk of fragility fractures in obesity and diabetes: A retro...

Non-obese diabetics had the highest risk of vertebral or hip fracture, whereas obese non-diabetics predominantly had...

02 Jul 2020

eCMEs

Date: 11th July 2020
Time: 5:00 pm to 6:00 pm

Key Trials

Can Teriparatide Maintain the Higher Body Heights and Prevent Refracture in Osteoporotic Vertebral Compression Fracture Patient After Vertebroplasty?

The present study assessed whether teriparatide (TP) could reduce refracture risk in osteoporotic vertebral compression fracture patients after...

Effect of Teriparatide Treatment on Mesenchymal Stromal Cells Functionality in Postmenopausal Osteoporotic Women with Atypical Femoral Fractures

Prevalence of atypical femoral fractures (AFF) induced by long-term treatment with bisphosphonates, ranges between 3.22 and 113.1 cases per 100,000...

Adalimumab Treatment Demonstrates Long-term Safety Profile in Japanese Patients with RA

This study determined the incidence of adverse drug reactions (ADRs) and factors associated with the safety and efficacy of adalimumab in Japanese...

Continuing versus Withdrawing Adalimumab Therapy in Patients with Active Non-radiographic Axial Spondyloarthritis

ABILITY-3 study is a randomized controlled trial evaluating the safety and efficacy of continuing versus withdrawing adalimumab therapy in patients...

Patient Education

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an inflammatory disease caused when the immune system attacks body’s own tissues. This leaflet gives an overvie...

Food Rich in Calcium and Vitamin D

Eating foods rich in calcium and vitamin D may help prevent bones from becoming weak and less likely to fracture.  This article gives a list of food...

Calcium – Vitamin D Recommended Dietary Allowance

Calcium and vitamin D are two essential nutrients long known for their roles in maintaining bone health. This article gives comprehensive recommended...

Our Publications

Zotide (Teriparatide ) Monograph

The currently available pharmacological treatments for osteoporosis are predominantly anti-resorptive. These inhibit osteoclast-mediated bone loss...

Hyruan (Hyaluronic Acid) Monograph

Osteoarthritis (OA) is the most common form of arthritis and is a major cause of debilitation for affected individuals. One of the nonsurgical...

Risofos Kit (Risedronate, Calcium citrate malate, Vitamin D3) – Data Sheet

This datasheet covers the rationale for Risofos kit formulation, its composition, dosage and administration information.

Calcinase (calcitonin) – Monograph

This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...

Slide Library

Intraarticular Hyaluronic acid for Osteoarthirits

The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...

 
Email this page
Osteoarthritis

This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...

 
Email this page
Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis

Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...

 
Email this page
Musculoskeletal Manifestations of Ulcerative Colitis

This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...

 
Email this page

Poll

Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-
Alendronate
67% (4 votes)
Risedronate
0% (0 votes)
Ibandronate
0% (0 votes)
Zoledronic acid
33% (2 votes)
Total votes: 6